Viewing Study NCT06439550


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-28 @ 5:19 AM
Study NCT ID: NCT06439550
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2024-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Treatment With Serplulimab,Trastuzumab and SOX in the HER-2 Positive GC/GEJC
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module